Clinical studies have also confirmed that there is a more potent response in prostate cancer patients with PTEN deficiency when they were treated with docetaxel combined with AZD8186 (53). This evidence concerns the gene PTEN and hyperinsulinemic hypoglycemia, familial, 4.